Orphazyme A/S (OZYMF)

USD 90.0

(0.0%)

Revenue Summary of Orphazyme A/S

  • Orphazyme A/S's latest annual revenue in 2023 was - DKK , down 0.0% from previous year.
  • Orphazyme A/S's latest quarterly revenue in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • Orphazyme A/S reported a annual revenue of - USD in annual revenue 2022, down -100.0% from previous year.
  • Orphazyme A/S reported a annual revenue of 36.19 Million DKK in annual revenue 2021, down 0.0% from previous year.
  • Orphazyme A/S reported a quarterly revenue of - DKK for 2023 FY, down 0.0% from previous quarter.
  • Orphazyme A/S reported a quarterly revenue of - USD for 2023 Q2, down 0.0% from previous quarter.

Annual Revenue Chart of Orphazyme A/S (2023 - 2014)

Historical Annual Revenue of Orphazyme A/S (2023 - 2014)

Year Revenue Revenue Growth
2023 - DKK 0.0%
2022 - USD -100.0%
2021 36.19 Million DKK 0.0%
2020 - DKK 0.0%
2019 - DKK 0.0%
2018 - DKK 0.0%
2017 - DKK 0.0%
2016 - DKK 0.0%
2015 - DKK 0.0%
2014 - DKK 0.0%

Peer Revenue Comparison of Orphazyme A/S

Name Revenue Revenue Difference
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 100.0%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD 100.0%
SQZ Biotechnologies Company 21.47 Million USD 100.0%
Evofem Biosciences, Inc. 18.21 Million USD 100.0%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 100.0%
Mesoblast Limited 5.9 Million USD 100.0%
Propanc Biopharma, Inc. - USD NaN%
Genus plc 668.8 Million USD 100.0%
VioQuest Pharmaceuticals, Inc. - USD NaN%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD 100.0%
Marizyme, Inc. 645.81 Thousand USD 100.0%
ContraFect Corporation - USD NaN%
Nymox Pharmaceutical Corporation - USD NaN%
PsyBio Therapeutics Corp. - USD NaN%
Sienna Biopharmaceuticals, Inc. - USD NaN%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD 100.0%
Intellipharmaceutics International Inc. 65.72 Thousand USD 100.0%
AXIM Biotechnologies, Inc. 39.51 Thousand USD 100.0%
MultiCell Technologies, Inc. 49.32 USD 100.0%
Accustem Sciences Inc. - USD NaN%
RVL Pharmaceuticals plc 49.72 Million USD 100.0%
EV Biologics, Inc. 48.9 Thousand USD 100.0%
Q BioMed Inc. 284.35 Thousand USD 100.0%
Emmaus Life Sciences, Inc. 29.59 Million USD 100.0%
Neon Bloom, Inc. - USD NaN%
Mosaic ImmunoEngineering Inc. - USD NaN%
Biomind Labs Inc. - USD NaN%
TetraLogic Pharmaceuticals Corporation - USD NaN%
Pharming Group N.V. 245.31 Million USD 100.0%
Oncotelic Therapeutics, Inc. 70 Thousand USD 100.0%
Skye Bioscience, Inc. - USD NaN%
Therapeutic Solutions International, Inc. 98.99 Thousand USD 100.0%
THC Farmaceuticals, Inc. - USD NaN%
Arch Therapeutics, Inc. 75.72 Thousand USD 100.0%
IMV Inc. - USD NaN%
Acro Biomedical Co., Ltd. 658.5 Thousand USD 100.0%
Curative Biotechnology, Inc. - USD NaN%
GB Sciences, Inc. - USD NaN%
Alpha Cognition Inc. - USD NaN%
HST Global, Inc. - USD NaN%
CSL Limited 14.69 Billion USD 100.0%
Halberd Corporation 999.00 USD 100.0%
Enzolytics Inc. 52.79 Thousand USD 100.0%
Resverlogix Corp. - USD NaN%
Affymax, Inc. 1.36 Million USD 100.0%
SYBLEU INC 11.69 Thousand USD 100.0%
Nuo Therapeutics, Inc. 608.52 Thousand USD 100.0%
argenx SE 1.22 Billion USD 100.0%
MetaStat, Inc. - USD NaN%
Northwest Biotherapeutics, Inc. 1.93 Million USD 100.0%
Enzon Pharmaceuticals, Inc. - USD NaN%
Arno Therapeutics, Inc. - USD NaN%
RespireRx Pharmaceuticals Inc. - USD NaN%
GeneThera, Inc. - USD NaN%
Inhibitor Therapeutics, Inc. - USD NaN%
AVAX Technologies, Inc. 617.38 Thousand USD 100.0%
Zenith Capital Corp. - USD NaN%
Genscript Biotech Corporation 839.52 Million USD 100.0%
Ember Therapeutics, Inc. - USD NaN%
Anthera Pharmaceuticals, Inc. - USD NaN%
Sigyn Therapeutics, Inc. - USD NaN%
WPD Pharmaceuticals Inc. - USD NaN%
American Oriental Bioengineering, Inc. 145.09 Million USD 100.0%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD 100.0%
Adynxx, Inc. - USD NaN%
Helix BioMedix, Inc. 997.72 Thousand USD 100.0%
GlobeStar Therapeutics Corporation - USD NaN%
VitaSpring Biomedical Co. Ltd. - USD NaN%
Capstone Therapeutics Corp. 48.35 Million USD 100.0%
Cotinga Pharmaceuticals Inc. - USD NaN%
BioStem Technologies, Inc. 16.68 Million USD 100.0%
ONE Bio Corp. 52.29 Million USD 100.0%
Reve Technologies, Inc. - USD NaN%
Burzynski Research Institute, Inc. - USD NaN%
Wesana Health Holdings Inc. - USD NaN%
Agentix Corp. - USD NaN%
LadRx Corporation - USD NaN%
Cell Source, Inc. - USD NaN%
ProtoKinetix, Incorporated - USD NaN%
Regen BioPharma, Inc. 236.56 Thousand USD 100.0%
Regen BioPharma, Inc. 236.56 Thousand USD 100.0%
NovAccess Global Inc. - USD NaN%
Endonovo Therapeutics, Inc. 140.24 Thousand USD 100.0%
Itoco Inc. - USD NaN%
Rasna Therapeutics, Inc. - USD NaN%
Pathfinder Cell Therapy, Inc. - USD NaN%
Kadimastem Ltd - USD NaN%
Oncology Pharma Inc. - USD NaN%
Institute of Biomedical Research Corp. - USD NaN%
CytoDyn Inc. - USD NaN%
Claritas Pharmaceuticals, Inc. - USD NaN%
NDT Pharmaceuticals Inc. - USD NaN%
Mobile Lads Corp. - USD NaN%
NanoSphere Health Sciences Inc. - USD NaN%
Qrons Inc. - USD NaN%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD 100.0%
Advanced Proteome Therapeutics Corporation - USD NaN%
Nascent Biotech, Inc. - USD NaN%
Rebus Holdings, Inc. - USD NaN%
ImmunoCellular Therapeutics, Ltd. - USD NaN%
International Stem Cell Corporation 7.78 Million USD 100.0%
Bioxytran, Inc. - USD NaN%
GlobeImmune, Inc. - USD NaN%
Predictive Technology Group, Inc. - USD NaN%
ProText Mobility, Inc. - USD NaN%
Cardax, Inc. - USD NaN%
VG Life Sciences Inc. - USD NaN%
Kaleido Biosciences, Inc. - USD NaN%
Advaxis, Inc. 13 Thousand USD 100.0%
Adhera Therapeutics, Inc. - USD NaN%
RenovaCare, Inc. - USD NaN%
Regnum Corp. - USD NaN%
Innovation Pharmaceuticals Inc. - USD NaN%
Neutra Corp. 39.53 Thousand USD 100.0%
Windtree Therapeutics, Inc. - USD NaN%
PureTech Health plc 3.33 Million USD 100.0%
Coeptis Therapeutics, Inc. - USD NaN%
IXICO plc 6.66 Million USD 100.0%
IntelGenx Technologies Corp. 1.03 Million USD 100.0%
Gelesis Holdings, Inc. 25.76 Million USD 100.0%
CSL Limited 14.8 Billion USD 100.0%
Cellectis S.A. 755 Thousand USD 100.0%